Objective To disentangle the impact of adherence from that of injecting drug status and
depressive syndrome on HIV clinical progression in a cohort of highly active anti-retroviral …

Affective disorders have been reported as the most common mental health problem in
persons with HIV infection. Depression has a significant impact on the quality of life of …

Objective: Key words: Medication adherence; Depressive disorder; Highly Active
Antiretroviral Therapy; HIV infectionTo determine the prevalence of depressive disorder in …

Background. Depression is highly prevalent among HIV-infected injection drug users (IDUs)
and has been associated with poor adherence to antiretroviral therapy and increased …

Background Depression is common in HIV-infected patients receiving antiretroviral therapy.
However, longitudinal studies addressing the role that depression might play in HIV clinical …

Objectives: To determine the impact of depression on highly active antiretroviral therapy
(HAART) adherence and clinical measures and investigate if selective serotonin reuptake …

Background: Antiretroviral regimens for HIV-infected patients require strict adherence.
Untreated depression has been associated with medication nonadherence. We proposed to …

Background A better understanding of the relationship between depression and HIV-related
outcomes, particularly as it relates to adherence to treatment, is critical to guide effective …

Background: Studies have identified several programmatic and nonprogrammatic indicators
that affect adherence to highly active antiretroviral therapy (HAART). Depression has been …

We examined the relationship between depression (symptom type, diagnostic severity, and
change over time) and adherence to HIV antiretroviral therapy (ART) with data from 3 …